| Amanda Hamrick Eckenrode, MD | |
|
200 W Grover St, Shelby, NC 28150-3708 | |
| (704) 487-8591 | |
| Not Available |
| Full Name | Amanda Hamrick Eckenrode |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 13 Years |
| Location | 200 W Grover St, Shelby, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639464720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2016-00529 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health Cleveland | Shelby, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.
The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.
Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.
A new educational program on chronic obstructive pulmonary disease (COPD), launched by NPS MedicineWise in March, includes a reminder on the critical importance of spirometry in diagnosing the condition, which is estimated to affect 1.45 million Australians.
› Verified 5 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.
The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.
Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.
A new educational program on chronic obstructive pulmonary disease (COPD), launched by NPS MedicineWise in March, includes a reminder on the critical importance of spirometry in diagnosing the condition, which is estimated to affect 1.45 million Australians.
› Verified 5 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.
The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.
Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.
A new educational program on chronic obstructive pulmonary disease (COPD), launched by NPS MedicineWise in March, includes a reminder on the critical importance of spirometry in diagnosing the condition, which is estimated to affect 1.45 million Australians.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Hamrick Eckenrode, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Amanda Hamrick Eckenrode, MD 200 W Grover St, Shelby, NC 28150-3708 Ph: (704) 487-8591 |
News Archive
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.
The U.S. is one of the wealthiest nations in the world but its citizens are far from the healthiest. In fact, the U.S. lags behind several other developed nations in life expectancy and other population health measures. These disparities persist despite the fact that the U.S. spends more money per capita than any other nation on healthcare delivery.
Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.
A new educational program on chronic obstructive pulmonary disease (COPD), launched by NPS MedicineWise in March, includes a reminder on the critical importance of spirometry in diagnosing the condition, which is estimated to affect 1.45 million Australians.
› Verified 5 days ago
Douglas Bryan Young, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 Fax: 704-480-9726 | |
Lauren Hutchinson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 105 Delta Park Dr, Shelby, NC 28150 Phone: 704-484-0464 | |
Michael Lynn Barringer, MD Surgery Medicare: Medicare Enrolled Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 | |
James M Potts, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 Fax: 704-480-9726 | |
Harry Douglas Hobson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 | |
Stephen Jonathan Von, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 | |
Tamera Beam Cox, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Grover St, Shelby, NC 28150 Phone: 704-487-8591 |